¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"tertiary calcium phosphate"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • calcium homeostasis
  • calcium infusion test
    Ä®½· ºÎÇϰ˻ç
  • calcium metabolism
    Ä®½·´ë»ç(¡­ÓÛÞó)
  • calcium oxalate
    ¼ö»êÄ®½·
  • calcium oxalate crystal
    ¼ö»ê Ä®½· °áÁ¤
  • calcium oxalate stone
  • calcium oxlate stones
    Ä®½·¿Á»ì·¹ÀÌÆ® °á¼® (¡­Ì¿à´)
  • calcium pyrophosphate crystal deposition
    Ä®½·ÇÇ·ÎÀλ꿰 °áÁ¤Ä§Âø(¡­×òß«ç¤ Ì¿ïÜöØó·)
  • calcium sodium exchange
    Ä®½·-³ªÆ®·ý ±³È¯(-Îßüµ)
  • calcium urate crystals
    ¿ä»êÄ®½·°áÁ¤
  • calcium, milk
    Ä®½· ¿ìÀ¯
  • calcium-binding protein
    Ä®½· °áÇմܹé(Ì¿ùêÓ±ÛÜ)
  • calcium/phosphorus metabolism
    Ä®½·/Àδë»ç
  • dihydrate calcium chloride
    À̼öÈ­¿°È­(ì£â©ûùç¤ûù)Ä®½·.
  • exchangeable calcium
    ±³È¯¼º Ä®½·
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • p-nitrophenyl phosphate
    p-³ªÀÌÆ®·ÎÆä´Ò Àλê(×òß«)
  • pyridoxal phosphate
    ÇǸ®µ¶»ì Àλê(×òß«)
  • pentose phosphate carboxylase
    Àλê(×òß«)ÆæÅ佺 Ä«¸£º¹½Ç·¹À̽º
  • pentose phosphate pathway
    Àλê(×òß«ÆæÅ佺 °æ·Î(ÌèÖØ)
  • phosphate
    Àλ꿰(×òß«ç¤)
  • phosphate acceptor peptide
    Àλê¼ö¿ë(×òß«áôé») ÆéŸÀ̵å
  • phosphate bond energy
    Àλê°áÇÕ(×ò߫̿ùê) ¿¡³ÊÁö
  • phosphate group
    Àλê±â(×òß«Ðñ)
  • phosphate group transfer
    Àλê±â ÀüÀÌ(×òß«Ðñï®ì¹)
  • phosphate potential
    Àλê ÀüÀ§(×òß«ï³êÈ)
  • phosphate regulon
    Àλê(×òß«)·¹±¼·Ð (ÔÒ) phoÁ¶ÀýÀ¯ÀüÀÚ(ðàï½ë¶îîí­)
  • phosphate transfer potential
    ÀλêÀüÀÌ ÀüÀ§(×òß«ï®ì¹ï³êÈ)
  • pyridoxal phosphate
    Àλê(×òß«) ÇǸ®µ¶»ì
  • reductive pentose phosphate cycle
    ȯ¿ø¼º(ü½êªàõ) Àλê(×òß«)ÆæÅ佺 ȸ·Î(üÞÖØ)
  • riboflavin phosphate
    ÀÎ»ê ¶óÀ̺¸Çöóºó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PD Doctor of Pharmacy; Dublin Pharmacopoeia; interpupillary distance; Paget disease; pancreatic duct; p...
PPP pain perception profile; palatopharyngoplasty; palmoplantar pustulosis; pentose phosphate pathway; p...
TCP T-complex protein; therapeutic continuous penicillin; total circulating protein; transcutaneous pace...
Ca   1) Carcinoma
  2) Cancer; ¾Ï
  3) Calcium
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
TCPL Tri-Calcium Phosphate Lysine
BCP biphasic calcium phosphate
P(i) phosphate and inorganic phosphate
Pi 6-phosphate , inorganic phosphate
45Ca2+ Calcium
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • calcium hydroxide
    ¼ö»êÈ­ Ä®½·
    ¹é»ö ºÐ¸»·Î Á¸ÀçÇÏ´Â ¿°. ±¹¼ÒÀûÀÎ ¼ö·ÅÁ¦·Î »ç¿ëµÈ´Ù.
  • calcium hypophosphate
    Ä®½· ¾ÆÀÎ»ê ¿°
    ÆÇÅäÅÙ »êÀÇ ¿ì¼±¼º À̼ºÃ¼ÀÇ Ä®½· ¿°, B º¹ÇÕü ºñŸ¹Î. ¹é»öÀÇ ºÐ¸». ´Ù¸¥ ºñŸ¹Î B¿Í °áÇÕÇÏ¿© ¿µ¾ç °ø±Þ¿øÀ¸·Î »ç¿ëµÈ´Ù.
  • calcium levulinate
    ·¹ºÒ¸° »ê Ä®½·
    Ä®½· º¸½ÀÁ¦. ¹é»ö °áÁ¤¼º ¶Ç´Â ¹«Á¤Çü ºÐ¸¸. Ä®½· °áÇÌÁõÀÇ Ä¡·á¿¡ Ä®½· º¸±ÞÁ¦·Î »ç¿ëµÈ´Ù.
  • calcium metabolism
    Ä®½·´ë»ç
    Ç÷ÀåÁßÀÇ Ä®½· ³óµµ¸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇÏ¸ç »ÀÀÇ ¼®È¸È­¸¦ À§ÇÑ Ä®½· °ø±ÞÀ» ÇÏ´Â »ýÈ­ÇÐÀû, »ý¸®ÇÐÀû °úÁ¤.
  • calcium oxide
    »êÈ­ Ä®½·
    ºÎ½Ä¼º ¾ËÄ®¸®, ºÎ½Ä¼º Åä·ùÀÇ ÀÏÁ¾. °ø±âÁßÀÇ ÀÌ»êȭź¼Ò¸¦ Èí¼öÇÏ´Â µ¥ ¾²À̸ç, °ø¾÷ÀûÀ¸·Î´Â °ª½Ñ ¾ËÄ®¸®·Î ±×¸®°í ¸ð¸£Å¸¸£ÀÇ ±âÀç·Î »ç¿ëµÈ´Ù.
  • calcium propionate
    ÇÁ·ÎÇǿ »ê Ä®½·
    ÇÁ·ÎÇǿ »êÀÇ Ä®½·¿°. Ç× Áø±Õ¼ºÀ» °®´Â´Ù. ´Üµ¶À¸·Î ¶Ç´Â ÇÁ·ÎÇǿ »ê ³ªÆ®·ýÀ̳ª ´Ù¸¥ ¿ä¼Ò¿Í °áÇÕÇÏ¿© ¹æºÎÁ¦¿Í ±¹¼ÒÀû Ç× Áø±ÕÁ¦·Î »ç¿ëµÈ´Ù.
  • calcium pyrophosphate dihydrate
    À̼öÈ­ ÇÇ·ÎÀλê Ä®½·
  • calcium salt
    Ä®½· ¿°
  • calcium sulfate
    Ȳ»ê Ä®½·
    õ¿¬ÀûÀ¸·Î¼­ ¼®°í CaSO4, 2H2O ¹× °æ¼®°í CaSO4·Î½á »êÃâ, ÀüÀÚ¸¦ Å¿ö¼­ CaSO4, 1/2H2OÀÇ ¼Ò¼®°í·Î¼­ »ç¿ëÇÑ´Ù. À̰Ϳ¡ ¹°À» °¡ÇÏ¿© Àλóü³»¿¡ ÁÖÀÔ½ÃŰ¸é ¼öºÐ¿¡¼­ 10ºÐ »çÀÌ¿¡ ¼®°í°¡ µÇ°í °æÈ­µÈ´Ù. ¼®°íÀÇ ¿ëÇØµµ´Â 42¡É·Î¼­ ÃÖ°íÀÌ´Ù. ¼®°í ¸ðÇü Á¦ÀÛ µî¿¡ »ç¿ëµÈ´Ù.
  • calcium sulfate bonded investment
    ¼®°í°è ¸Å¸ôÀç, ¼®°í °áÇÕ ¸Å¸ôÀç
  • calcium sulfate hemihydrate
    ¹Ý¼ö ¼®°í
    À̼ö ¼®°í¸¦ °¥¾Æ¼­ 230¡­248¢µÀÇ ¿Âµµ¸¦ °¡ÇÏ¸é °áÁ¤Ã¼ ÁßÀÇ ÀϺΰ¡ »ÀÀÚ ³ª°¡ Ä¡°ú¿ë °æ¼®°í°¡ µÈ´Ù. È­ÇÐ ±¸Á¶½Ä CaSO4, 1/2H2O.
  • calcium-channel blocker
    Ä®½· Â÷´ÜÁ¦, Ä®½· Åë·Î Â÷´ÜÁ¦
  • calcium/phosphorus metabolism
    Ä®½·/ÀÎ ´ë»ç
  • dioctyl calcium sulfosuccinate
    ¼³Æ÷È£¹Ú»ê´ÙÀÌ¿ÁÆ¿ Ä®½·
    ¹é»öÀÇ Á©¶óƾ °°Àº °íü. ¹°¿¡ ¾à°£ ³ìÀ¸¸ç ½ÀÀ±Á¦ ¹× º¯ÀÇ ¿¬È­Á¦·Î »ç¿ëµÈ´Ù.
  • exchangeable calcium
    ±³È¯¼º Ä®½·
    Á¶Á÷ ¼Ó¿¡ ÀÖÀ¸¸é¼­ Ç÷¾× »çÀÌ¿¡ »óÈ£ ±³È¯ °¡´ÉÇÑ Ä®½·.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
calcium ATPase <enzyme> Usually used of the calcium pumping ATPase present in high concentration as an integral membrane protein of the sarcoplasmic reticulum of muscle.
This pump lowers the cytoplasmic calcium level and causes contraction to stop. Normal function of the pump seems to require a local phospholipid environment from which cholesterol is excluded.
(18 Nov 1997)
calcium benzoylpas Calcium 4-benzamidosalicylate;an antituberculous agent.
(05 Mar 2000)
calcium-binding protein <biochemistry> There are two main groups of calcium binding proteins, those that are similar to calmodulin and are called EF hand proteins and those that bind calcium and phospholipid (e.g. Lipocortin) and that have been grouped under the generic name of annexins.
Many other proteins will bind calcium, although the binding site usually has considerable homology with the calcium-binding domains of calmodulin. They can act as transport proteins, regulator proteins or activator proteins.
There is also a vitamin D-dependent variant which is a protein that plays a fundamental role in the vitamin d mediated transport of calcium in reptiles, amphibians, birds and mammals. It is found in the intestine, kidneys, egg shell gland, brain, and possibly other organs. Its molecular weight is species dependent.
(12 May 2002)
calcium bromide Used to meet the same indications as potassium bromide.
(05 Mar 2000)
calcium-calmodulin-activated histone 3 arginine kinase <enzyme> From nuclear extracts of dividing and quiescent rat heart endothelial cells; represents a new class of ca-cam-dependent kinases which phosphorylate arg
Registry number: EC 2.7.10.-
Synonym: ca(2+)-calmodulin-activated histone 3 arg kinase, ca-cam h3 kinase
(26 Jun 1999)
calcium-calmodulin-dependent phosphodiesterase <enzyme> Hydrolyzes both cgmp and camp; induced during mitogenesis
Registry number: EC 3.1.4.-
Synonym: ca-cam-phosphodiesterase, calmodulin-dependent cgmp phosphodiesterase
(26 Jun 1999)
calcium-calmodulin dependent protein kinase <enzyme> A calmodulin-dependent enzyme that catalyses the phosphorylation of proteins. This enzyme is also sometimes dependent on calcium. A wide range of proteins can act as acceptor, including vimentin, synapsin, glycogen synthase, myosin light chains, and the microtubule-associated proteins.
Registry number: EC 2.7.10.-
(12 Dec 1998)
calcium carbide CaC2;blackish crystalline lumps which when in contact with water yield acetylene gas.
(05 Mar 2000)
calcium carbimide <drug> This drug is used to treat alcoholism, if a person takes this drug and then drinks any alcohol at all, they will get sick (headache, nausea, vertigo, etc.)
(09 Oct 1997)
calcium carbonate An astringent, an antacid
(27 Sep 1997)
calcium caseinate The form of casein present in cow's milk; used in dietetic preparations; has been used for diarrhoea in infants.
(05 Mar 2000)
calcium channel <physiology> A membrane channel that is specific for calcium. It is a voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorised as l, t, n, or p types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins.
(12 May 2002)
calcium channel agonist <pharmacology> Agents that increase calcium influx into calcium channels of excitable tissues.
This causes vasoconstriction in vascular smooth muscle and/or cardiac muscle cells as well as stimulation of insulin release from pancreatic islets. Therefore, tissue-selective calcium agonists have the potential to combat cardiac failure and endocrinological disorders. They have been used primarily in experimental studies in cell and tissue culture.
(12 Dec 1998)
calcium channel antagonist <pharmacology> A class of drugs that act by selective inhibition of calcium ion influx through or across cell membranes or on the release and binding of calcium in intracellular pools.
Calcium channel blockers are used primarily in the treatment of certain heart conditions and stroke. As they are inducers of vascular and other smooth muscle relaxation, they are also used in the treatment of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms.
Synonym: calcium antagonist, calcium channel-blocker, slow channel-blocking agent.
(12 May 2002)
calcium channel-blocker <pharmacology> A class of drugs that act by selective inhibition of calcium ion influx through or across cell membranes or on the release and binding of calcium in intracellular pools.
Calcium channel blockers are used primarily in the treatment of certain heart conditions and stroke. As they are inducers of vascular and other smooth muscle relaxation, they are also used in the treatment of hypertension and cerebrovascular spasms, as myocardial protective agents, and in the relaxation of uterine spasms.
Synonym: calcium antagonist, calcium channel-blocker, slow channel-blocking agent.
(12 May 2002)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á